CytoDyn: After FDA Requests More Data On COVID-19 Treatment, This Analyst Remains Sidelined
FDA Approves Nucala as First Biologic Treatment for HES
The window is wide open as four more biotechs join the go-go IPO class of 2020
3D printed nasal swabs work as well as commercial swabs for COVID-19 diagnostic testing
Ultrapotent antibody mix blocks COVID-19 virus attachment
Putting virtual rehab for stroke patients to the test
3 "Strong Buy" Healthcare Stocks Under $5 With Triple-Digit Growth Prospects
Gilead To Pay $97M To Settle Kickback Debacle Over Letairis Drug
Likely molecular mechanisms of SARS-CoV-2 pathogenesis are revealed by network biology
3 "Strong Buy" Stocks That Are Flirting With a Bottom
Scoop: ARCH’s Bob Nelsen is backing an mRNA upstart that promises to upend the entire manufacturing side of the global business
FDA’s review date for BMS’ ide-cel sneaks under the CVR wire
Stanford psychologists investigate COVID-19’s mental toll on teenagers
3 research-based ways to cope with the uncertainties of pandemic life
Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 50%
Tips for living online – lessons from six months of the COVID-19 pandemic
Teva Launches Two Digital Inhalers For Asthma Patients
Fred Hutch-led clinical trial shows new smartphone app helps smokers quit
These 2 Penny Stocks Could Rally All the Way to $11, Says Cantor
Goldman Adds BJ’s Wholesale To Conviction Buy, Lifts PT
AstraZeneca-Merck’s Lynparza Gets Recommended By EU For Prostate, Ovarian Cancers
AlloVir Gains 14% On FDA Trial Nod For Covid-19 Therapy
Eli Lilly’s Verzenio Treatment Lowers Breast Cancer Recurrence By 25%
UC study sheds light on cancer treatment, COVID-19
EU regulator backs dexamethasone as Covid-19 treatment
Wells Fargo: These 2 Stocks Could Deliver Triple-Digit Wins
Potential new drug to mitigate SARS-CoV-2 infection consequences
AstraZeneca’s Imfinzi Trial Shows Survival In Lung Cancer Patients
Moderna broadens R&D scope with Vertex, Chiesi alliances
NIH launches trial of Rigel drug for severe Covid-19